Kenneth B. Roberts, MD
Research & Publications
Biography
News
Locations
Research Summary
My clinical research interests have been translational and practical, emphasizing combined modality therapy in cancer management, late effects of therapy including secondary malignancies, and the utilization of brachytherapy (implanted radiation sources) in both malignant and benign disease.
Specialized Terms: Cervix cancer and hypoxic cell cytotoxins; Brachytherapy; Pediatric malignancies; Hodgkin's disease; Health services research
Extensive Research Description
During my first ten years on the Yale faculty, I participated in clinical trials evaluating the efficacy of bioreductive alkylating agents as an adjunct to radiotherapy in cervix cancer. A Phase III study comparing radiotherapy alone with radiotherapy plus Mitomycin C for cervix cancer has been completed in Venezuela with results showing a significant improvement in disease-free survival with the addition of Mitomycin C, which is a hypoxic cell cytotoxin.
For several years, I had been collaborating with Interventional Cardiology and Medical Physics in a clinical program utilizing coronary brachytherapy to manage in-stent restenosis. Some current or upcoming clinical research projects include:
1) modifying radiation dose and volume in advanced stage Hodgkin’s disease based on response to initial chemotherapy (a cooperative group trial);
2) the effects of prostate edema during brachytherapy on modulating radiation dose delivery;
3) the changes in second malignancies seen after Hodgkins Lymphoma therapy with shift away from primary extended field radiotherapy to combined chemotherapy and low dose involved field radiotherapy
4) an examination of the economic forces that drive the use and demand for radiotherapeutic modalities, often with poorly developed evidence.
Regarding this latter concept, in the management of localized prostate cancer, brachytherapy is in a decline while Intensity Modulated and Image Guided Radiotherapy is in ascendancy for complex reasons. In early stage breast cancer, there is an increasing trend toward partial breast irradiation using 3D conformal radiotherapy or brachytherapy. Coronary brachytherapy had experienced a several year surge in usage and interest amongst cardiologists, but now is less frequently needed due to the efficacy of drug eluting stents, a complementary albeit expensive technology. Palliative radiotherapy in terminally ill cancer patients has become less frequently used, due in part to the capitated reimbursement for hospice care and the relatively high expense and inconvenience of radiotherapy versus medical therapy.
Coauthors
Research Interests
Brachytherapy; Uterine Cervical Neoplasms; Cytotoxins; Hodgkin Disease; Radiation Oncology
Selected Publications
- NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.Zelenetz A, Gordon L, Abramson J, Advani R, Andreadis B, Bartlett N, Budde L, Caimi P, Chang J, Christian B, DeVos S, Dholaria B, Fayad L, Habermann T, Hamid M, Hernandez-Ilizaliturri F, Hu B, Kaminski M, Karimi Y, Kelsey C, King R, Krivacic S, LaCasce A, Lim M, Messmer M, Narkhede M, Rabinovitch R, Ramakrishnan P, Reid E, Roberts K, Saeed H, Smith S, Svoboda J, Swinnen L, Tuscano J, Vose J, Dwyer M, Sundar H. NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023. Journal Of The National Comprehensive Cancer Network 2023, 21: 1118-1131. PMID: 37935098, DOI: 10.6004/jnccn.2023.0057.
- Radiotherapy Utilization and Outcomes on a Contemporary Trial for Pediatric High-Risk Hodgkin Lymphoma StudyHoppe B, Castellino S, Pei Q, Charpentier A, Keller F, Vega R, Roberts K, Parikh R, Punnett A, Parsons S, McCarten K, Flampouri S, Kessel S, Wu Y, Cho S, Kelly K, Hodgson D. Radiotherapy Utilization and Outcomes on a Contemporary Trial for Pediatric High-Risk Hodgkin Lymphoma Study. International Journal Of Radiation Oncology • Biology • Physics 2023, 117: s62-s63. DOI: 10.1016/j.ijrobp.2023.06.362.
- Risk of Subsequent Neoplasms in Childhood Cancer Survivors After Radiation Therapy: A PENTEC Comprehensive ReviewCasey D, Vogelius I, Brodin N, Roberts K, Avanzo M, Moni J, Owens C, Ronckers C, Constine L, Bentzen S, Olch A. Risk of Subsequent Neoplasms in Childhood Cancer Survivors After Radiation Therapy: A PENTEC Comprehensive Review. International Journal Of Radiation Oncology • Biology • Physics 2023, 119: 640-654. PMID: 37777927, DOI: 10.1016/j.ijrobp.2023.07.025.
- Prognostic value of chest x‐ray‐ and CT‐defined large mediastinal adenopathy in high‐risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831Lo A, Lee I, Pei Q, Wu Y, McCarten K, Hoppe B, Hodgson D, Roberts K, Milgrom S, Kessel S, Cole P, Kelly K, Cho S. Prognostic value of chest x‐ray‐ and CT‐defined large mediastinal adenopathy in high‐risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831. Pediatric Blood & Cancer 2023, 70: e30452. PMID: 37243975, PMCID: PMC10546608, DOI: 10.1002/pbc.30452.
- Radiation Therapy Use in Refractory and Relapsed Adolescent and Young Adult Hodgkin Lymphoma: A Report from the Children's Oncology GroupMailhot Vega R, Harker-Murray P, Forlenza C, Cole P, Kelly K, Milgrom S, Parikh R, Hodgson D, Castellino S, Kahn J, Roberts K, Constine L, Hoppe B. Radiation Therapy Use in Refractory and Relapsed Adolescent and Young Adult Hodgkin Lymphoma: A Report from the Children's Oncology Group. International Journal Of Radiation Oncology • Biology • Physics 2023, 117: 400-403. PMID: 37116589, PMCID: PMC10655744, DOI: 10.1016/j.ijrobp.2023.04.022.
- Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group studyMilgrom S, Kim J, Pei Q, Lee I, Hoppe B, Wu Y, Hodgson D, Kessel S, McCarten K, Roberts K, Lo A, Cole P, Kelly K, Cho S. Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study. British Journal Of Haematology 2023, 201: 1192-1199. PMID: 36922022, PMCID: PMC10247420, DOI: 10.1111/bjh.18734.
- ACR–ARS Practice Parameter for the Performance of Total Body IrradiationReilly M, Dandapani S, Kumar K, Constine L, Fogh S, Roberts K, Small W, Schechter N. ACR–ARS Practice Parameter for the Performance of Total Body Irradiation. American Journal Of Clinical Oncology 2023, 46: 185-192. PMID: 36907934, DOI: 10.1097/coc.0000000000000997.
- Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation TherapyHoppe B, McCarten K, Pei Q, Kessel S, Alazraki A, Mhlanga J, Lai H, Eutsler E, Hodgson D, Roberts K, Charpentier A, Keller F, Voss S, Wu Y, Cho S, Kelly K, Castellino S. Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2023, 116: 1025-1030. PMID: 36868525, PMCID: PMC10363760, DOI: 10.1016/j.ijrobp.2023.02.020.
- Risk of Subsequent Central Nervous System Neoplasms in Childhood Cancer Survivors after Radiation Therapy: Results from the Pediatric Normal Tissue Effects in the Clinic (PENTEC) CollaborationCasey D, Brodin P, Roberts K, Vogelius I, Avanzo M, Moni J, Owens C, Ronckers C, Constine L, Bentzen S, Olch A. Risk of Subsequent Central Nervous System Neoplasms in Childhood Cancer Survivors after Radiation Therapy: Results from the Pediatric Normal Tissue Effects in the Clinic (PENTEC) Collaboration. International Journal Of Radiation Oncology • Biology • Physics 2022, 114: s122-s123. DOI: 10.1016/j.ijrobp.2022.07.568.
- Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology GroupParikh RR, Kelly KM, Hodgson DC, Hoppe BS, McCarten KM, Karolczuk K, Pei Q, Wu Y, Cho SY, Schwartz C, Cole PD, Roberts K. Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology Group. International Journal Of Radiation Oncology • Biology • Physics 2021, 112: 890-900. PMID: 34767937, PMCID: PMC9038118, DOI: 10.1016/j.ijrobp.2021.10.152.
- The Evolution of Children's Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac ToxicityLo A, Liu A, Liu Q, Yasui Y, Castellino S, Kelly K, Herrera A, Friedberg J, Friedman D, Schwartz C, Bergeron-Gravel S, Dama H, Roberts K, Constine L, Hodgson D. The Evolution of Children's Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity. Blood 2021, 138: 881-881. DOI: 10.1182/blood-2021-147678.
- PET-Based Quantification of Baseline Metabolic Tumor Burden Improves Risk Stratification in High-Risk Hodgkin Lymphoma: A Children's Oncology Group StudyMilgrom S, Kim J, Hoppe B, Pei Q, Wu Y, Lo A, Kessel S, McCarten K, Roberts K, Hodgson D, Schwartz C, Friedman D, Kelly K, Cho S. PET-Based Quantification of Baseline Metabolic Tumor Burden Improves Risk Stratification in High-Risk Hodgkin Lymphoma: A Children's Oncology Group Study. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: s79-s80. DOI: 10.1016/j.ijrobp.2021.07.192.
- NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.Zelenetz AD, Gordon LI, Chang JE, Christian B, Abramson JS, Advani RH, Bartlett NL, Budde LE, Caimi PF, De Vos S, Dholaria B, Fakhri B, Fayad LE, Glenn MJ, Habermann TM, Hernandez-Ilizaliturri F, Hsi E, Hu B, Kaminski MS, Kelsey CR, Khan N, Krivacic S, LaCasce AS, Lim M, Narkhede M, Rabinovitch R, Ramakrishnan P, Reid E, Roberts KB, Saeed H, Smith SD, Svoboda J, Swinnen LJ, Tuscano J, Vose JM, Dwyer MA, Sundar H. NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021. Journal Of The National Comprehensive Cancer Network 2021, 19: 1218-1230. PMID: 34781267, DOI: 10.6004/jnccn.2021.0054.
- Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin LymphomaVega R, Castellino SM, Pei Q, Parsons S, Roberts KB, Hodgson D, Charpentier AM, Fitzgerald TJ, Kessel SK, Keller FG, Kelly K, Hoppe BS. Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma. International Journal Of Particle Therapy 2021, 8: 55-57. PMID: 35127976, PMCID: PMC8768892, DOI: 10.14338/ijpt-21-00012.1.
- Pediatric Hodgkin Lymphoma, Version 3.2021.Flerlage J, Hiniker S, Armenian S, Benya E, Bobbey A, Chang V, Cooper S, Coulter D, Cuglievan B, Hoppe B, Isenalumhe L, Kelly K, Kersun L, Lamble A, Larrier N, Magee J, Oduro K, Pacheco M, Price A, Roberts K, Smith C, Sohani A, Trovillion E, Walling E, Xavier A, Burns J, Campbell M. Pediatric Hodgkin Lymphoma, Version 3.2021. Journal Of The National Comprehensive Cancer Network 2021, 19: 733-754. PMID: 34214968, DOI: 10.6004/jnccn.2021.0027.
- Pediatric classical Hodgkin lymphomaLo AC, Dieckmann K, Pelz T, Gallop‐Evans E, Engenhart‐Cabillic R, Vordermark D, Kelly KM, Schwartz CL, Constine LS, Roberts K, Hodgson D. Pediatric classical Hodgkin lymphoma. Pediatric Blood & Cancer 2021, 68: e28562. PMID: 33818890, DOI: 10.1002/pbc.28562.
- Primary Mediastinal B Cell Lymphoma in the Positron-Emission Tomography Era Executive Summary of the American Radium Society Appropriate Use CriteriaHoppe BS, Advani R, Milgrom SA, Bakst RL, Ballas LK, Dabaja BS, Flowers CR, Ha CS, Mansur DB, Metzger ML, Pinnix CC, Plastaras JP, Roberts KB, Smith SM, Terezakis SA, Kirwan JM, Constine LS. Primary Mediastinal B Cell Lymphoma in the Positron-Emission Tomography Era Executive Summary of the American Radium Society Appropriate Use Criteria. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: 36-44. PMID: 33774076, DOI: 10.1016/j.ijrobp.2021.03.035.
- Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American radium society appropriate use criteriaBallas LK, Metzger ML, Milgrom SA, Advani R, Bakst RL, Dabaja BS, Flowers CR, Ha CS, Hoppe BS, Mansur DB, Pinnix CC, Plastaras JP, Roberts KB, Smith SM, Terezakis SA, Constine LS. Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American radium society appropriate use criteria. Leukemia & Lymphoma 2020, 62: 1057-1065. PMID: 33274673, DOI: 10.1080/10428194.2020.1852559.
- Prognostic Value of Chest X-ray and CT Defined Large Mediastinal Adenopathy in High Risk Pediatric Hodgkin Lymphoma (COG AHOD0831)Lo A, Lee I, Pei Q, McCarten K, Hoppe B, Hodgson D, Roberts K, Milgrom S, Kelly K, Cho S. Prognostic Value of Chest X-ray and CT Defined Large Mediastinal Adenopathy in High Risk Pediatric Hodgkin Lymphoma (COG AHOD0831). International Journal Of Radiation Oncology • Biology • Physics 2020, 108: s177-s178. DOI: 10.1016/j.ijrobp.2020.07.959.
- Patterns of Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children’s Oncology GroupParikh R, Hoppe B, Hodgson D, McCarten K, Pei Q, Cho S, Schwartz C, Cole P, Kelly K, Roberts K. Patterns of Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children’s Oncology Group. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: s36-s37. DOI: 10.1016/j.ijrobp.2020.07.2140.
- Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolvedShallis RM, Gale RP, Lazarus HM, Roberts KB, Xu ML, Seropian SE, Gore SD, Podoltsev NA. Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved. Blood Reviews 2020, 47: 100773. PMID: 33213985, DOI: 10.1016/j.blre.2020.100773.
- Tumor-targeted pH-low insertion peptide delivery of theranostic gadolinium nanoparticles for image-guided nanoparticle-enhanced radiation therapyLiu W, Deacon J, Yan H, Sun B, Liu Y, Hegan D, Li Q, Coman D, Parent M, Hyder F, Roberts K, Nath R, Tillement O, Engelman D, Glazer P. Tumor-targeted pH-low insertion peptide delivery of theranostic gadolinium nanoparticles for image-guided nanoparticle-enhanced radiation therapy. Translational Oncology 2020, 13: 100839. PMID: 32763504, PMCID: PMC7408331, DOI: 10.1016/j.tranon.2020.100839.
- Outcomes for allogeneic stem cell transplantation in refractory mycosis fungoides and primary cutaneous gamma Delta T cell lymphomasIsufi I, Seropian S, Gowda L, Wilson LD, Roberts K, Girardi M, Perreault S, Foss F. Outcomes for allogeneic stem cell transplantation in refractory mycosis fungoides and primary cutaneous gamma Delta T cell lymphomas. Leukemia & Lymphoma 2020, 61: 2955-2961. PMID: 32643494, DOI: 10.1080/10428194.2020.1790555.
- A general-purpose Monte Carlo particle transport code based on inverse transform sampling for radiotherapy dose calculationLiang Y, Muhammad W, Hart GR, Nartowt BJ, Chen ZJ, Yu JB, Roberts KB, Duncan JS, Deng J. A general-purpose Monte Carlo particle transport code based on inverse transform sampling for radiotherapy dose calculation. Scientific Reports 2020, 10: 9808. PMID: 32555530, PMCID: PMC7300009, DOI: 10.1038/s41598-020-66844-7.
- Reduction in Cardiac Radiation Dose Among Children Receiving Mediastinal RT: Comparison of Involved-Site vs Involved-Field RT Delivered in Three Children’s Oncology Group TrialsGravel S, Khandwala M, Wolden S, Castellino S, Friedman D, Kelly K, Roberts K, Constine L, Schwartz C, Fitzgerald T, Hoppe B, Hodgson D. Reduction in Cardiac Radiation Dose Among Children Receiving Mediastinal RT: Comparison of Involved-Site vs Involved-Field RT Delivered in Three Children’s Oncology Group Trials. Klinische Pädiatrie 2020, 232: 102-103. DOI: 10.1055/s-0040-1701884.
- Predictive Value of PET-CT in Patients with T-Cell Lymphoma Undergoing Autologous and Allogeneic Stem Cell TransplantIsufi I, Chandhok N, Boddu P, Pucar D, Seropian S, Gowda L, Perreault S, Wilson L, Roberts K, Foss F. Predictive Value of PET-CT in Patients with T-Cell Lymphoma Undergoing Autologous and Allogeneic Stem Cell Transplant. Transplantation And Cellular Therapy 2020, 26: s244. DOI: 10.1016/j.bbmt.2019.12.492.
- Predictors of Lymph Node Involvement by Soft Tissue Sarcoma of the Trunk and Extremity: An Analysis of the National Cancer DatabaseMiccio JA, Jairam V, Gao S, Augustyn A, Oladeru OT, Onderdonk BE, Chowdhary M, Han D, Khan S, Friedlaender G, Lindskog DM, Desphande HA, Osborn H, Roberts KB, Patel KR. Predictors of Lymph Node Involvement by Soft Tissue Sarcoma of the Trunk and Extremity: An Analysis of the National Cancer Database. Cureus 2019, 11: e6038. PMID: 31824805, PMCID: PMC6886621, DOI: 10.7759/cureus.6038.
- Response‐adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children’s Oncology GroupKelly KM, Cole PD, Pei Q, Bush R, Roberts KB, Hodgson DC, McCarten KM, Cho SY, Schwartz C. Response‐adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children’s Oncology Group. British Journal Of Haematology 2019, 187: 39-48. PMID: 31180135, PMCID: PMC6857800, DOI: 10.1111/bjh.16014.
- NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019.Zelenetz AD, Gordon LI, Abramson JS, Advani RH, Bartlett NL, Caimi PF, Chang JE, Chavez JC, Christian B, Fayad LE, Glenn MJ, Habermann TM, Lee Harris N, Hernandez-Ilizaliturri F, Kaminski MS, Kelsey CR, Khan N, Krivacic S, LaCasce AS, Mehta A, Nademanee A, Rabinovitch R, Reddy N, Reid E, Roberts KB, Smith SD, Snyder ED, Swinnen LJ, Vose JM, Dwyer MA, Sundar H. NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019. Journal Of The National Comprehensive Cancer Network 2019, 17: 650-661. PMID: 31200358, DOI: 10.6004/jnccn.2019.0029.
- Moody D. Wharam Jr, MD, FACR, FASTRO, July 22, 1941-August 10, 2018.Jabbour SK, Timmerman RD, Raben D, DeWeese TL, Donaldson SS, Thomas P, Laurie F, Bishop-Jodoin M, Tarbell N, Wolden S, Halperin E, Constine LS, Haas-Kogan D, Marcus K, Freeman C, Terezakis S, Million L, Smith MA, Mendenhall NP, Marcus RB, Cherlow J, Kalapurakal J, Breneman J, Yock T, MacDonald S, Laack N, Donahue B, Indelicato D, Michalski J, Perkins S, Kachnic L, Esiashvilli N, Roberts KB, FitzGerald TJ. Moody D. Wharam Jr, MD, FACR, FASTRO, July 22, 1941-August 10, 2018. International Journal Of Radiation Oncology, Biology, Physics 2019, 103: 1026-1030. PMID: 30900552, DOI: 10.1016/j.ijrobp.2019.01.004.
- Results of a pilot/phase II study of gamma knife radiosurgery for brain metastases and implications for future prospective clinical trialsYu J, Singh C, Bindra R, Contessa J, Husain Z, Hansen J, Park H, Roberts K, Bond J, Tien C, Guo F, Colaco R, Housri N, Magnuson W, Mahajan A, Omay S, Chiang V. Results of a pilot/phase II study of gamma knife radiosurgery for brain metastases and implications for future prospective clinical trials. Journal Of Radiation Oncology 2019, 8: 39-46. DOI: 10.1007/s13566-018-0370-7.
- Larry Emanuel Kun, March 10, 1946-May 27, 2018.FitzGerald TJ, Donaldson SS, Wharam M, Laurie F, Bishop-Jodoin M, Moni J, Tarbell N, Shulkin B, McCarville E, Merchant T, Krasin M, Wolden S, Halperin E, Constine LS, Haas-Kogan D, Marcus K, Freeman C, Wilson JF, Hoppe R, Cox J, Terezakis S, Million L, Smith MA, Mendenhall NP, Marcus RB, Cherlow J, Kalapurakal J, Breneman J, Yock T, MacDonald S, Laack N, Donahue B, Indelicato D, Michalski J, Perkins S, Kachnic L, Choy H, Braunstein S, Esiashvilli N, Roberts KB. Larry Emanuel Kun, March 10, 1946-May 27, 2018. International Journal Of Radiation Oncology, Biology, Physics 2019, 103: 8-14. PMID: 30563668, DOI: 10.1016/j.ijrobp.2018.08.018.
- A Pilot/Phase II Study of Stereotactic Radiosurgery for Brain Metastases Using Rational Dose SelectionYu J, Singh C, Bindra R, Contessa J, Husain Z, Hansen J, Park H, Roberts K, Bond J, Tien C, Guo F, Colaco R, Housri N, Magnuson W, Omay B, Chiang V. A Pilot/Phase II Study of Stereotactic Radiosurgery for Brain Metastases Using Rational Dose Selection. International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e372-e373. DOI: 10.1016/j.ijrobp.2018.07.1113.
- Predictors of Lymph Node Involvement by Soft Tissue Sarcoma: An Analysis of the National Cancer Database (NCDB)Miccio J, Jairam V, Gao S, Augustyn A, Oladeru O, Onderdonk B, Costa J, Han D, Khan S, Friedlaender G, Lindskog D, Deshpande H, Tara H, Osborn H, Roberts K, Patel K. Predictors of Lymph Node Involvement by Soft Tissue Sarcoma: An Analysis of the National Cancer Database (NCDB). International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e335. DOI: 10.1016/j.ijrobp.2018.07.1028.
- Monte Carlo dosimetry modeling of focused kV x‐ray radiotherapy of eye diseases with potential nanoparticle dose enhancementYan H, Ma X, Sun W, Mendez S, Stryker S, Starr‐Baier S, Delliturri G, Zhu D, Nath R, Chen Z, Roberts K, MacDonald CA, Liu W. Monte Carlo dosimetry modeling of focused kV x‐ray radiotherapy of eye diseases with potential nanoparticle dose enhancement. Medical Physics 2018, 45: 4720-4733. PMID: 30133705, DOI: 10.1002/mp.13144.
- Associations of preoperative breast magnetic resonance imaging with subsequent mastectomy and breast cancer mortalityWang SY, Long JB, Killelea BK, Evans SB, Roberts KB, Silber AL, Davidoff AJ, Sedghi T, Gross CP. Associations of preoperative breast magnetic resonance imaging with subsequent mastectomy and breast cancer mortality. Breast Cancer Research And Treatment 2018, 172: 453-461. PMID: 30099634, PMCID: PMC6193824, DOI: 10.1007/s10549-018-4919-3.
- 441 Reduced Intensity Conditioning with Pentostatin and Low-Dose TBI in Patients with Relapsed Hematologic MalignanciesIsufi I, Seropian S, Cooper D, Roberts K, Wilson L, Girardi M, Perreault S, Foss F. 441 Reduced Intensity Conditioning with Pentostatin and Low-Dose TBI in Patients with Relapsed Hematologic Malignancies. Transplantation And Cellular Therapy 2018, 24: s307. DOI: 10.1016/j.bbmt.2017.12.353.
- On the use of bolus for pacemaker dose measurement and reduction in radiation therapyYan H, Guo F, Zhu D, Stryker S, Trumpore S, Roberts K, Higgins S, Nath R, Chen Z, Liu W. On the use of bolus for pacemaker dose measurement and reduction in radiation therapy. Journal Of Applied Clinical Medical Physics 2017, 19: 125-131. PMID: 29152840, PMCID: PMC5768029, DOI: 10.1002/acm2.12229.
- CNS LeukemiaAn Y, Roberts K. CNS Leukemia. 2017, 311-333. DOI: 10.1007/978-3-319-55430-3_17.
- Annual Facility Treatment Volume and Patient Survival for Mycosis Fungoides and Sézary SyndromeKann B, Park H, Yeboa D, Aneja S, Girardi M, Foss F, Roberts K, Wilson L. Annual Facility Treatment Volume and Patient Survival for Mycosis Fungoides and Sézary Syndrome. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e430. DOI: 10.1016/j.ijrobp.2017.06.1632.
- Annual Facility Treatment Volume and Patient Survival for Mycosis Fungoides and Sézary SyndromeKann BH, Park HS, Yeboa DN, Aneja S, Girardi M, Foss FM, Roberts KB, Wilson LD. Annual Facility Treatment Volume and Patient Survival for Mycosis Fungoides and Sézary Syndrome. Clinical Lymphoma Myeloma & Leukemia 2017, 17: 520-526.e2. PMID: 28655598, DOI: 10.1016/j.clml.2017.05.017.
- ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma.Winkfield KM, Advani RH, Ballas LK, Dabaja BS, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mansur DB, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Younes A, Constine LS. ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma. Oncology 2016, 30: 1099-103, 1106-8. PMID: 27987203, PMCID: PMC7440297.
- A Novel Prognostic Index for Ocular Adnexal LymphomaMeeks M, Park H, Yu J, Roberts K, Foss F, Wilson L. A Novel Prognostic Index for Ocular Adnexal Lymphoma. Blood 2016, 128: 3597-3597. DOI: 10.1182/blood.v128.22.3597.3597.
- ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and IIDhakal S, Advani R, Ballas LK, Dabaja BS, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II. American Journal Of Clinical Oncology 2016, 39: 535-544. PMID: 27643717, PMCID: PMC7433865, DOI: 10.1097/coc.0000000000000331.
- Postoperative Radiotherapy Patterns of Care and Survival Implications for Medulloblastoma in Young ChildrenKann BH, Park HS, Lester-Coll NH, Yeboa DN, Benitez V, Khan AJ, Bindra RS, Marks AM, Roberts KB. Postoperative Radiotherapy Patterns of Care and Survival Implications for Medulloblastoma in Young Children. JAMA Oncology 2016, 2: 1574-1581. PMID: 27491009, DOI: 10.1001/jamaoncol.2016.2547.
- Adjuvant Radiation Therapy Patterns and Survival Implications for Medulloblastoma in Young ChildrenKann B, Park H, Lester-Coll N, Yeboa D, Benitez V, Bindra R, Khan A, Marks A, Roberts K. Adjuvant Radiation Therapy Patterns and Survival Implications for Medulloblastoma in Young Children. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s230-s231. DOI: 10.1016/j.ijrobp.2016.06.573.
- Radiation Oncology Drug Prescription Patterns in Medicare Part DMaroongroge S, Roberts K, Yu J. Radiation Oncology Drug Prescription Patterns in Medicare Part D. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e395-e396. DOI: 10.1016/j.ijrobp.2016.06.1625.
- A Comparison of Pharmacologic Pain and Psychiatric Management by Radiation Oncologists and Medical Oncologists in Medicare Part DMaroongroge S, Roberts K, Yu J. A Comparison of Pharmacologic Pain and Psychiatric Management by Radiation Oncologists and Medical Oncologists in Medicare Part D. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e511-e512. DOI: 10.1016/j.ijrobp.2016.06.1911.
- Consensus Report From the Stockholm Pediatric Proton Therapy ConferenceIndelicato DJ, Merchant T, Laperriere N, Lassen Y, Vennarini S, Wolden S, Hartsell W, Pankuch M, Brandal P, Law CC, Taylor R, Laskar S, Okcu MF, Bouffet E, Mandeville H, Björk-Eriksson T, Nilsson K, Nyström H, Constine LS, Story M, Timmermann B, Roberts K, Kortmann RD. Consensus Report From the Stockholm Pediatric Proton Therapy Conference. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: 387-392. PMID: 27598806, DOI: 10.1016/j.ijrobp.2016.06.2446.
- Addition of Chemotherapy to Adjuvant Radiation Therapy is Associated With Improved Overall Survival in Adult MedulloblastomaKann B, Lester-Coll N, Park H, Yeboa D, Bindra R, Becker K, Baehring J, Roberts K. Addition of Chemotherapy to Adjuvant Radiation Therapy is Associated With Improved Overall Survival in Adult Medulloblastoma. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s27-s28. DOI: 10.1016/j.ijrobp.2016.06.080.
- NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.Horwitz SM, Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Fayad LE, Fisher RI, Glenn MJ, Habermann TM, Lee Harris N, Hernandez-Ilizaliturri F, Hoppe RT, Kaminski MS, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Lunning M, Nademanee A, Press O, Rabinovitch R, Reddy N, Reid E, Roberts K, Saad AA, Sokol L, Swinnen LJ, Vose JM, Yahalom J, Zafar N, Dwyer M, Sundar H, Porcu P. NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016. Journal Of The National Comprehensive Cancer Network : JNCCN 2016, 14: 1067-79. PMID: 27587620, DOI: 10.6004/jnccn.2016.0117.
- Adjuvant chemotherapy and overall survival in adult medulloblastomaKann BH, Lester-Coll NH, Park HS, Yeboa DN, Kelly JR, Baehring JM, Becker KP, Yu JB, Bindra RS, Roberts KB. Adjuvant chemotherapy and overall survival in adult medulloblastoma. Neuro-Oncology 2016, 19: 259-269. PMID: 27540083, PMCID: PMC5464064, DOI: 10.1093/neuonc/now150.
- ACR Appropriateness Criteria® Hodgkin Lymphoma—Unfavorable Clinical Stage I and IIRoberts KB, Younes A, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Constine LS. ACR Appropriateness Criteria® Hodgkin Lymphoma—Unfavorable Clinical Stage I and II. American Journal Of Clinical Oncology 2016, 39: 384-395. PMID: 27299425, DOI: 10.1097/coc.0000000000000294.
- MB-38ADJUVANT RADIOTHERAPY PATTERNS OF CARE AND SURVIVAL IMPLICATIONS FOR MEDULLOBLASTOMA IN YOUNG CHILDRENKann B, Park H, Lester-Coll N, Yeboa D, Benitez V, Bindra R, Khan A, Marks A, Roberts K. MB-38ADJUVANT RADIOTHERAPY PATTERNS OF CARE AND SURVIVAL IMPLICATIONS FOR MEDULLOBLASTOMA IN YOUNG CHILDREN. Neuro-Oncology 2016, 18: iii105-iii105. PMCID: PMC4903595, DOI: 10.1093/neuonc/now076.36.
- The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomasStahl JM, Corso CD, Park HS, An Y, Rutter CE, Han D, Roberts KB. The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomas. European Journal Of Surgical Oncology 2016, 43: 168-174. PMID: 27335080, DOI: 10.1016/j.ejso.2016.05.031.
- Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situWang SY, Long JB, Killelea BK, Evans SB, Roberts KB, Silber A, Gross CP. Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situ. Breast Cancer Research And Treatment 2016, 158: 139-148. PMID: 27287780, PMCID: PMC5554869, DOI: 10.1007/s10549-016-3858-0.
- Diffuse Large B-Cell Lymphoma Version 1.2016.Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Fayad LE, Fisher RI, Glenn MJ, Habermann TM, Lee Harris N, Hernandez-Ilizaliturri F, Hoppe RT, Horwitz SM, Kaminski MS, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Lunning M, Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Roberts K, Saad AA, Sokol L, Swinnen LJ, Vose JM, Yahalom J, Zafar N, Dwyer M, Sundar H. Diffuse Large B-Cell Lymphoma Version 1.2016. Journal Of The National Comprehensive Cancer Network : JNCCN 2016, 14: 196-231. PMID: 26850490, DOI: 10.6004/jnccn.2016.0023.
- Chapter 74 Pediatric Hodgkin's LymphomaRoberts K, Kelly K, Constine L. Chapter 74 Pediatric Hodgkin's Lymphoma. 2016, 1464-1485.e5. DOI: 10.1016/b978-0-323-24098-7.00074-5.
- Phase III Study of Response Adapted Therapy for the Treatment of Children with Newly Diagnosed Very High Risk Hodgkin Lymphoma (Stages IIIB/IVB) (AHOD0831): A Report from the Children's Oncology GroupKelly K, Cole P, Chen L, Roberts K, Hodgson D, McCarten K, Cho S, Schwartz C. Phase III Study of Response Adapted Therapy for the Treatment of Children with Newly Diagnosed Very High Risk Hodgkin Lymphoma (Stages IIIB/IVB) (AHOD0831): A Report from the Children's Oncology Group. Blood 2015, 126: 3927. DOI: 10.1182/blood.v126.23.3927.3927.
- ACR Appropriateness Criteria® Diffuse Large B-Cell LymphomaDabaja BS, Advani R, Hodgson DC, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma. American Journal Of Clinical Oncology 2015, 38: 610-620. PMID: 26583344, DOI: 10.1097/coc.0000000000000215.
- Preoperative Breast Magnetic Resonance Imaging and Contralateral Breast Cancer Occurrence Among Older Women With Breast CancerWang SY, Long JB, Killelea BK, Evans SB, Roberts KB, Silber A, Gross CP. Preoperative Breast Magnetic Resonance Imaging and Contralateral Breast Cancer Occurrence Among Older Women With Breast Cancer. Journal Of Clinical Oncology 2015, 34: 321-328. PMID: 26628465, PMCID: PMC4872032, DOI: 10.1200/jco.2015.62.9741.
- Pediatric Brainstem Glioma Survival After Definitive Radiation Therapy With or Without Concurrent Chemotherapy: A Nationwide ComparisonPark H, Yeboa D, Lester-Coll N, Corso C, Mancini B, Bindra R, Roberts K, Yu J, Rutter C. Pediatric Brainstem Glioma Survival After Definitive Radiation Therapy With or Without Concurrent Chemotherapy: A Nationwide Comparison. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e504-e505. DOI: 10.1016/j.ijrobp.2015.07.1836.
- The Effect of Margin Status and Radiation Therapy on Survival in Adult Retroperitoneal Soft Tissue SarcomasStahl J, Corso C, An Y, Aneja S, Rutter C, Park H, Mancini B, Yeboa D, Lester-Coll N, Han D, Roberts K. The Effect of Margin Status and Radiation Therapy on Survival in Adult Retroperitoneal Soft Tissue Sarcomas. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e638. DOI: 10.1016/j.ijrobp.2015.07.2175.
- A report of metachronous orbital involvement by IgG4 disease treated successfully with low-dose radiation therapyRutter CE, Mancini BR, Roberts KB. A report of metachronous orbital involvement by IgG4 disease treated successfully with low-dose radiation therapy. Practical Radiation Oncology 2015, 6: 74-77. PMID: 26577005, DOI: 10.1016/j.prro.2015.09.007.
- The Role of Patient Factors, Cancer Characteristics, and Treatment Patterns in the Cost of Care for Medicare Beneficiaries with Breast CancerXu X, Herrin J, Soulos PR, Saraf A, Roberts KB, Killelea BK, Wang SY, Long JB, Wang R, Ma X, Gross CP. The Role of Patient Factors, Cancer Characteristics, and Treatment Patterns in the Cost of Care for Medicare Beneficiaries with Breast Cancer. Health Services Research 2015, 51: 167-186. PMID: 26119176, PMCID: PMC4722219, DOI: 10.1111/1475-6773.12328.
- Hematopoietic stem cell transplantation for primary cutaneous γδ T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphomaGibson JF, Alpdogan O, Subtil A, Girardi M, Wilson LD, Roberts K, Foss F. Hematopoietic stem cell transplantation for primary cutaneous γδ T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma. Journal Of The American Academy Of Dermatology 2015, 72: 1010-1015.e5. PMID: 25981001, DOI: 10.1016/j.jaad.2015.01.003.
- Historical trends of radiotherapy use in prevalent malignancies over 38 years in SEERYeboa D, Aneja S, Montana G, Roberts K, Yu J. Historical trends of radiotherapy use in prevalent malignancies over 38 years in SEER. Journal Of Radiation Oncology 2015, 4: 11-17. DOI: 10.1007/s13566-015-0182-y.
- ACR Appropriateness Criteria Follow-up of Hodgkin LymphomaHa CS, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith S, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR Appropriateness Criteria Follow-up of Hodgkin Lymphoma. Journal Of The American College Of Radiology 2014, 11: 1026-1033.e3. PMID: 25278496, DOI: 10.1016/j.jacr.2014.07.038.
- Historical Trends of Radiation Therapy Use in Prevalent MalignanciesYeboa D, Roberts K, Aneja S, Yu J. Historical Trends of Radiation Therapy Use in Prevalent Malignancies. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s599-s600. DOI: 10.1016/j.ijrobp.2014.05.1796.
- ResponseSen S, Wang SY, Soulos PR, Frick KD, Long JB, Roberts KB, Yu JB, Evans SB, Chagpar AB, Gross CP. Response. Journal Of The National Cancer Institute 2014, 106: dju198. PMID: 25114276, PMCID: PMC4200056, DOI: 10.1093/jnci/dju198.
- Examining the Cost-Effectiveness of Radiation Therapy Among Older Women With Favorable-Risk Breast CancerSen S, Wang SY, Soulos PR, Frick KD, Long JB, Roberts KB, Yu JB, Evans SB, Chagpar AB, Gross CP. Examining the Cost-Effectiveness of Radiation Therapy Among Older Women With Favorable-Risk Breast Cancer. Journal Of The National Cancer Institute 2014, 106: dju008. PMID: 24598714, PMCID: PMC3982782, DOI: 10.1093/jnci/dju008.
- ACR appropriateness Criteria® pediatric Hodgkin lymphomaTerezakis SA, Metzger ML, Hodgson DC, Schwartz CL, Advani R, Flowers CR, Hoppe BS, Ng A, Roberts KB, Shapiro R, Wilder RB, Yunes MJ, Constine LS. ACR appropriateness Criteria® pediatric Hodgkin lymphoma. Pediatric Blood & Cancer 2014, 61: 1305-1312. PMID: 24616347, DOI: 10.1002/pbc.24983.
- Delayed Cerebral Vasculopathy Following Cranial Radiation Therapy for Pediatric TumorsWang C, Roberts KB, Bindra RS, Chiang VL, Yu JB. Delayed Cerebral Vasculopathy Following Cranial Radiation Therapy for Pediatric Tumors. Pediatric Neurology 2014, 50: 549-556. PMID: 24739378, DOI: 10.1016/j.pediatrneurol.2013.09.018.
- Abstract P6-07-05: Regional variation in Medicare expenditures for older women with localized breast cancerXu X, Soulos P, Herrin J, Ross J, Saraf A, Roberts K, Killelea B, Wang S, Long J, Wang R, Ma X, Gross C. Abstract P6-07-05: Regional variation in Medicare expenditures for older women with localized breast cancer. Cancer Research 2013, 73: p6-07-05-p6-07-05. DOI: 10.1158/0008-5472.sabcs13-p6-07-05.
- For-profit hospital ownership status and use of brachytherapy after breast-conserving surgerySen S, Soulos PR, Herrin J, Roberts KB, Yu JB, Lesnikoski BA, Ross JS, Krumholz HM, Gross CP. For-profit hospital ownership status and use of brachytherapy after breast-conserving surgery. Surgery 2013, 155: 776-788. PMID: 24787104, PMCID: PMC4008843, DOI: 10.1016/j.surg.2013.12.009.
- Evidence-Based Cardiovascular Management of Patients Receiving Radiotherapy to the HeartTaylor B, Evans S, Roberts K. Evidence-Based Cardiovascular Management of Patients Receiving Radiotherapy to the Heart. 2013, 409-420. DOI: 10.1007/978-1-4471-4441-0_28.
- ACR Appropriateness Criteria: Localized nodal indolent lymphoma.Hoppe BS, Hodgson DC, Advani R, Dabaja BS, Flowers CR, Ha CS, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR Appropriateness Criteria: Localized nodal indolent lymphoma. Oncology 2013, 27: 786-94. PMID: 24133827.
- Reply to L.W. Cuttino et alPresley CJ, Soulos PR, Herrin J, Roberts KB, Yu JB, Gross CP. Reply to L.W. Cuttino et al. Journal Of Clinical Oncology 2013, 31: 2227-2229. PMID: 23901421, DOI: 10.1200/jco.2013.49.0441.
- For-profit hospital ownership status and use of brachytherapy after breast-conserving surgery.Sen S, Soulos P, Herrin J, Roberts K, Yu J, Lesnikoski B, Ross J, Krumholz H, Gross C. For-profit hospital ownership status and use of brachytherapy after breast-conserving surgery. Journal Of Clinical Oncology 2013, 31: 6511-6511. DOI: 10.1200/jco.2013.31.15_suppl.6511.
- ResponseYu JB, Soulos PR, Herrin J, Cramer LD, Roberts KB, Gross CP. Response. Journal Of The National Cancer Institute 2013, 105: 748-749. PMID: 23814886, DOI: 10.1093/jnci/djt076.
- Variation in Receipt of Radiation Therapy After Breast-conserving SurgeryFeinstein AJ, Soulos PR, Long JB, Herrin J, Roberts KB, Yu JB, Gross CP. Variation in Receipt of Radiation Therapy After Breast-conserving Surgery. Medical Care 2013, 51: 330-338. PMID: 23151590, PMCID: PMC3596448, DOI: 10.1097/mlr.0b013e31827631b0.
- Prostate Edema Characterization Using Image Registration and PCAJiang Y, Zhai Y, Papademetris X, Roberts K, Nath R, Chen Z. Prostate Edema Characterization Using Image Registration and PCA. 2013, 39: 1754-1757. DOI: 10.1007/978-3-642-29305-4_461.
- Proton Versus Intensity-Modulated Radiotherapy for Prostate Cancer: Patterns of Care and Early ToxicityYu JB, Soulos PR, Herrin J, Cramer LD, Potosky AL, Roberts KB, Gross CP. Proton Versus Intensity-Modulated Radiotherapy for Prostate Cancer: Patterns of Care and Early Toxicity. Journal Of The National Cancer Institute 2012, 105: 25-32. PMID: 23243199, PMCID: PMC3536640, DOI: 10.1093/jnci/djs463.
- Historical Trends in the Use of Radiation Therapy for Pediatric Cancers: 1973-2008Jairam V, Roberts KB, Yu JB. Historical Trends in the Use of Radiation Therapy for Pediatric Cancers: 1973-2008. International Journal Of Radiation Oncology • Biology • Physics 2012, 85: e151-e155. PMID: 23273995, PMCID: PMC3636568, DOI: 10.1016/j.ijrobp.2012.10.007.
- Pediatric non-rhabdomyosarcoma soft tissue sarcomasMancini B, Roberts K. Pediatric non-rhabdomyosarcoma soft tissue sarcomas. Journal Of Radiation Oncology 2012, 2: 135-148. DOI: 10.1007/s13566-012-0081-4.
- The Adoption of New Adjuvant Radiation Therapy Modalities Among Medicare Beneficiaries With Breast Cancer: Clinical Correlates and Cost ImplicationsRoberts KB, Soulos PR, Herrin J, Yu JB, Long JB, Dostaler E, Gross CP. The Adoption of New Adjuvant Radiation Therapy Modalities Among Medicare Beneficiaries With Breast Cancer: Clinical Correlates and Cost Implications. International Journal Of Radiation Oncology • Biology • Physics 2012, 85: 1186-1192. PMID: 23182396, PMCID: PMC3606652, DOI: 10.1016/j.ijrobp.2012.10.009.
- A 35-year History of Radiation Therapy Utilization Across the United StatesAneja S, Roberts K, Wilson L, Haffty B, Montana G, Yu J. A 35-year History of Radiation Therapy Utilization Across the United States. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s546-s547. DOI: 10.1016/j.ijrobp.2012.07.1457.
- Proton Radiation Therapy for Prostate Cancer in the Medicare Population: Patterns of Care and Comparison of Early Toxicity With Intensity Modulated Radiation TherapyYu J, Soulos P, Herrin J, Cramer L, Potosky A, Roberts K, Gross C. Proton Radiation Therapy for Prostate Cancer in the Medicare Population: Patterns of Care and Comparison of Early Toxicity With Intensity Modulated Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s13. DOI: 10.1016/j.ijrobp.2012.07.040.
- Skull Base Chordoma and Chondrosarcoma: An Update of National Radiation Therapy Patterns and Survival Outcomes in the Modern EraPark H, Roberts K, Yu J. Skull Base Chordoma and Chondrosarcoma: An Update of National Radiation Therapy Patterns and Survival Outcomes in the Modern Era. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s286-s287. DOI: 10.1016/j.ijrobp.2012.07.748.
- Understanding Costs and Value of Newer Radiation Modalities Among Older Women With Breast CancerSen S, Soulos P, Frick K, Long J, Roberts K, Yu J, Evans S, Chagpar A, Gross C. Understanding Costs and Value of Newer Radiation Modalities Among Older Women With Breast Cancer. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s35. DOI: 10.1016/j.ijrobp.2012.07.096.
- Temporal Trends in Radiation Modalities Among Older Women With Favorable Risk Breast CancerRoberts K, Soulos P, Yu J, Evans S, Long J, Gross C. Temporal Trends in Radiation Modalities Among Older Women With Favorable Risk Breast Cancer. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s34. DOI: 10.1016/j.ijrobp.2012.07.093.
- Survival for Patients With Inflammatory Breast Cancer Receiving Mastectomy Is Associated With Radiation Sequence and RaceTaylor B, Evans S, Roberts K, Yu J. Survival for Patients With Inflammatory Breast Cancer Receiving Mastectomy Is Associated With Radiation Sequence and Race. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s222-s223. DOI: 10.1016/j.ijrobp.2012.07.578.
- Patterns of Use and Short-Term Complications of Breast Brachytherapy in the National Medicare Population From 2008–2009Presley CJ, Soulos PR, Herrin J, Roberts KB, Yu JB, Killelea B, Lesnikoski BA, Long JB, Gross CP. Patterns of Use and Short-Term Complications of Breast Brachytherapy in the National Medicare Population From 2008–2009. Journal Of Clinical Oncology 2012, 30: 4302-4307. PMID: 23091103, PMCID: PMC3675700, DOI: 10.1200/jco.2012.43.5297.
- Patterns of subsequent malignancies after Hodgkin lymphoma in children and adultsOmer B, Kadan‐Lottick N, Roberts KB, Wang R, Demsky C, Kupfer GM, Cooper D, Seropian S, Ma X. Patterns of subsequent malignancies after Hodgkin lymphoma in children and adults. British Journal Of Haematology 2012, 158: 615-625. PMID: 22775513, DOI: 10.1111/j.1365-2141.2012.09211.x.
- Short-term complications and use of breast brachytherapy in the national Medicare population in 2008-2009.Presley C, Soulos P, Herrin J, Roberts K, Yu J, Killelea B, Lesnikoski B, Long J, Gross C. Short-term complications and use of breast brachytherapy in the national Medicare population in 2008-2009. Journal Of Clinical Oncology 2012, 30: 1030-1030. DOI: 10.1200/jco.2012.30.15_suppl.1030.
- Proton radiotherapy for prostate cancer in the Medicare population: Patterns of care and comparison of early toxicity with IMRT.Yu J, Soulos P, Cramer L, Roberts K, Herrin J, Potosky A, Gross C. Proton radiotherapy for prostate cancer in the Medicare population: Patterns of care and comparison of early toxicity with IMRT. Journal Of Clinical Oncology 2012, 30: 4651-4651. DOI: 10.1200/jco.2012.30.15_suppl.4651.
- Assessing the Impact of a Cooperative Group Trial on Breast Cancer Care in the Medicare PopulationSoulos PR, Yu JB, Roberts KB, Raldow AC, Herrin J, Long JB, Gross CP. Assessing the Impact of a Cooperative Group Trial on Breast Cancer Care in the Medicare Population. Journal Of Clinical Oncology 2012, 30: 1601-1607. PMID: 22393088, PMCID: PMC3383112, DOI: 10.1200/jco.2011.39.4890.
- The influence of physician densities and patient characteristics on the decision to treat prostate cancer patients with varying clinical benefit.Yu J, Aneja S, Makarov D, Roberts K, Gross C. The influence of physician densities and patient characteristics on the decision to treat prostate cancer patients with varying clinical benefit. Journal Of Clinical Oncology 2012, 30: 19-19. DOI: 10.1200/jco.2012.30.5_suppl.19.
- The influence of regional radiation oncologist and urologist capacities on treatment choice for prostate cancer management.Yu J, Aneja S, Makarov D, Roberts K, Gross C. The influence of regional radiation oncologist and urologist capacities on treatment choice for prostate cancer management. Journal Of Clinical Oncology 2012, 30: 108-108. DOI: 10.1200/jco.2012.30.5_suppl.108.
- The influence of regional radiation oncologist and urologist capacities on treatment choice for prostate cancer management.Yu JB, Aneja S, Makarov DV, Roberts KB, Gross CP. The influence of regional radiation oncologist and urologist capacities on treatment choice for prostate cancer management. Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology 2012, 30: 108. PMID: 27968002.
- Chapter 72 Pediatric Hodgkin's LymphomaRoberts K, Hudson M, Constine L. Chapter 72 Pediatric Hodgkin's Lymphoma. 2012, 1489-1503. DOI: 10.1016/b978-1-4377-1637-5.00072-9.
- Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysisBuscariollo DL, Park HS, Roberts KB, Yu JB. Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis. Cancer 2011, 118: 4212-4219. PMID: 22213196, DOI: 10.1002/cncr.27373.
- The Influence of Regional Radiation Oncologist and Urologist Capacities on Treatment Choice for Prostate CancerAneja S, Gross C, Makarov D, Roberts K, Yu J. The Influence of Regional Radiation Oncologist and Urologist Capacities on Treatment Choice for Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s552. DOI: 10.1016/j.ijrobp.2011.06.869.
- The impact of prostate edema on cell survival and tumor control after permanent interstitial brachytherapy for early stage prostate cancersChen Z, Roberts K, Decker R, Pathare P, Rockwell S, Nath R. The impact of prostate edema on cell survival and tumor control after permanent interstitial brachytherapy for early stage prostate cancers. Physics In Medicine And Biology 2011, 56: 4895-4912. PMID: 21772076, PMCID: PMC3154133, DOI: 10.1088/0031-9155/56/15/016.
- TH‐A‐220‐09: A Study of Prostate Edema Resolution Pattern by Principle Component AnalysisJiang Y, Zhai Y, Papademetris X, Roberts K, Pathare P, Nath R, Chen Z. TH‐A‐220‐09: A Study of Prostate Edema Resolution Pattern by Principle Component Analysis. Medical Physics 2011, 38: 3847-3847. DOI: 10.1118/1.3613487.
- Geographic Analysis of the Radiation Oncology WorkforceAneja S, Smith BD, Gross CP, Wilson LD, Haffty BG, Roberts K, Yu JB. Geographic Analysis of the Radiation Oncology Workforce. International Journal Of Radiation Oncology • Biology • Physics 2011, 82: 1723-1729. PMID: 21493013, DOI: 10.1016/j.ijrobp.2011.01.070.
- Testicular Doses in Image-Guided Radiotherapy of Prostate CancerDeng J, Chen Z, Yu JB, Roberts KB, Peschel RE, Nath R. Testicular Doses in Image-Guided Radiotherapy of Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2011, 82: e39-e47. PMID: 21489702, DOI: 10.1016/j.ijrobp.2011.01.071.
- Kilovoltage Imaging Doses in the Radiotherapy of Pediatric Cancer PatientsDeng J, Chen Z, Roberts KB, Nath R. Kilovoltage Imaging Doses in the Radiotherapy of Pediatric Cancer Patients. International Journal Of Radiation Oncology • Biology • Physics 2011, 82: 1680-1688. PMID: 21477943, DOI: 10.1016/j.ijrobp.2011.01.062.
- In Reply to Dr. RicklesFalit B, Gross C, Roberts K. In Reply to Dr. Rickles. International Journal Of Radiation Oncology • Biology • Physics 2011, 79: 1280-1281. DOI: 10.1016/j.ijrobp.2010.09.064.
- In Reply to Drs. Zimberg and OlssonFalit B, Gross C, Roberts K. In Reply to Drs. Zimberg and Olsson. International Journal Of Radiation Oncology • Biology • Physics 2010, 78: 1607-1608. DOI: 10.1016/j.ijrobp.2010.07.2000.
- Integrated Prostate Cancer Centers and Over-Utilization of IMRT: A Close Look at Fee-for-Service Medicine in Radiation OncologyFalit BP, Gross CP, Roberts KB. Integrated Prostate Cancer Centers and Over-Utilization of IMRT: A Close Look at Fee-for-Service Medicine in Radiation Oncology. International Journal Of Radiation Oncology • Biology • Physics 2010, 76: 1285-1288. PMID: 20338470, DOI: 10.1016/j.ijrobp.2009.10.060.
- Baseline Utilization of Breast Radiotherapy Before Institution of the Medicare Practice Quality Reporting InitiativeSmith BD, Smith GL, Roberts KB, Buchholz TA. Baseline Utilization of Breast Radiotherapy Before Institution of the Medicare Practice Quality Reporting Initiative. International Journal Of Radiation Oncology • Biology • Physics 2009, 74: 1506-1512. PMID: 19395182, DOI: 10.1016/j.ijrobp.2008.10.012.
- Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials.The Chemoradiation for Cervical Cancer Meta-analysis Collaboration (CCCMAC), Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol. 2008 Dec 10;26(35):5802-12
- Detection of Occult Brain Metastasis with High Resolution MRI using Double vs. Single Dose GadoliniumChamberlain D, Yu J, Roberts K, Higgins S, Mani S, Ozturk A, Chiang V, Knisely J. Detection of Occult Brain Metastasis with High Resolution MRI using Double vs. Single Dose Gadolinium. International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s230-s231. DOI: 10.1016/j.ijrobp.2008.06.702.
- Impact of using Different Tissue Heterogeneity Correction Algorithms on the Successful Implementation of Stereotactic Body Radiotherapy Programs for Lung TumorsChen Z, Deng J, Decker R, Roberts K, Wilson L, Nath R. Impact of using Different Tissue Heterogeneity Correction Algorithms on the Successful Implementation of Stereotactic Body Radiotherapy Programs for Lung Tumors. International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s456-s457. DOI: 10.1016/j.ijrobp.2008.06.1849.
- On the Need to Compensate for Edema-Induced Dose Reductions in Preplanned 131Cs Prostate BrachytherapyChen ZJ, Deng J, Roberts K, Nath R. On the Need to Compensate for Edema-Induced Dose Reductions in Preplanned 131Cs Prostate Brachytherapy. International Journal Of Radiation Oncology • Biology • Physics 2007, 70: 303-310. PMID: 17980500, PMCID: PMC2289996, DOI: 10.1016/j.ijrobp.2007.09.007.
- Analysis of Gastric MALT Lymphomas Identified in the SEER DatabaseBlitzblau R, Yu J, Wilson L, Roberts K. Analysis of Gastric MALT Lymphomas Identified in the SEER Database. International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s537-s538. DOI: 10.1016/j.ijrobp.2007.07.1779.
- Characterization of Non-Gastric MALT Lymphomas Identified in the SEER DatabaseRoberts K, Blitzblau R, Wilson L. Characterization of Non-Gastric MALT Lymphomas Identified in the SEER Database. International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s532-s533. DOI: 10.1016/j.ijrobp.2007.07.1771.
- Development of a statewide hospital plan for radiologic emergenciesDainiak N, Delli Carpini D, Bohan M, Werdmann M, Wilds E, Barlow A, Beck C, Cheng D, Daly N, Glazer P, Mas P, Nath R, Piontek G, Price K, Albanese J, Roberts K, Salner AL, Rockwell S. Development of a statewide hospital plan for radiologic emergencies. International Journal Of Radiation Oncology • Biology • Physics 2006, 65: 16.e1-16.e15. PMID: 16618574, DOI: 10.1016/j.ijrobp.2005.12.047.
- Potential impact of prostate edema on the dosimetry of permanent seed implants using the new (model CS‐1) seedsChen Z, Deng J, Roberts K, Nath R. Potential impact of prostate edema on the dosimetry of permanent seed implants using the new (model CS‐1) seeds. Medical Physics 2006, 33: 968-975. PMID: 16696473, DOI: 10.1118/1.2179170.
- PET imaging for suspected residual tumour or thoracic recurrence of non-small cell lung cancer after pneumonectomyRoberts KB, Manus MP, Hicks RJ, Rischin D, Wirth A, Wright GM, Ball DL. PET imaging for suspected residual tumour or thoracic recurrence of non-small cell lung cancer after pneumonectomy. Lung Cancer 2005, 47: 49-57. PMID: 15603854, DOI: 10.1016/j.lungcan.2004.06.014.
- Relation of clinical success in coronary brachytherapy to doseSingh HS, Yue N, Azimi N, Nath R, Roberts KB, Pfau S. Relation of clinical success in coronary brachytherapy to dose. The American Journal Of Cardiology 2004, 94: 847-852. PMID: 15464663, DOI: 10.1016/j.amjcard.2004.06.016.
- Optimization of dose distributions for bifurcated coronary vessels treated with catheter‐based photon and beta emitters using the simulated annealing algorithmYue N, Roberts KB, Son H, Khosravi S, Pfau SE, Nath R. Optimization of dose distributions for bifurcated coronary vessels treated with catheter‐based photon and beta emitters using the simulated annealing algorithm. Medical Physics 2004, 31: 2610-2622. PMID: 15487744, DOI: 10.1118/1.1783533.
- Effects of vessel curvature on dose distributions in catheter-based intravascular brachytherapy for various radionuclidesYue N, Roberts K, Nath R. Effects of vessel curvature on dose distributions in catheter-based intravascular brachytherapy for various radionuclides. Cardiovascular Revascularization Medicine 2004, 5: 142-150. PMID: 15721850, DOI: 10.1016/j.carrad.2004.08.002.
- 808-1 Dose threshold for clinical success in coronary brachytherapy: A nested case-control studySingh H, Yue N, Roberts K, Nath R, Pfau S. 808-1 Dose threshold for clinical success in coronary brachytherapy: A nested case-control study. Journal Of The American College Of Cardiology 2004, 43: a54. DOI: 10.1016/s0735-1097(04)90229-x.
- Brachytherapy for in-stent restenosis in general interventional practice A single institution's experience using four radiation devicesSingh HS, Roberts KB, Yue N, Nath R, Song GH, Azimi N, Pfau S. Brachytherapy for in-stent restenosis in general interventional practice A single institution's experience using four radiation devices. Cardiovascular Revascularization Medicine 2003, 4: 126-132. PMID: 14984712, DOI: 10.1016/s1522-1865(03)00183-5.
- Dose distributions in bifurcated coronary vessels treated with catheter‐based photon and beta emitters in intravascular brachytherapyYue N, Roberts KB, Pfau SE, Nath R. Dose distributions in bifurcated coronary vessels treated with catheter‐based photon and beta emitters in intravascular brachytherapy. Medical Physics 2003, 30: 1628-1636. PMID: 12906180, DOI: 10.1118/1.1582813.
- Gamma knife radiosurgery for the treatment of trigeminal neuralgia: early results of the yale experienceKim D, de Lotbiniere A, Roberts K, Bond J, Knisely J. Gamma knife radiosurgery for the treatment of trigeminal neuralgia: early results of the yale experience. International Journal Of Radiation Oncology • Biology • Physics 2001, 51: 61. DOI: 10.1016/s0360-3016(01)01936-8.
- Dosimetric penumbra effects in catheter-based intravascular brachytherapy using a centered photon or beta line sourceYue N, Nath R, Roberts K. Dosimetric penumbra effects in catheter-based intravascular brachytherapy using a centered photon or beta line source. Cardiovascular Revascularization Medicine 2001, 2: 32-38. PMID: 11068253, DOI: 10.1016/s1522-1865(00)00044-5.
- Radiation dose selection in Hodgkin’s disease patients with large mediastinal adenopathy treated with combined modality therapyElconin J, Roberts K, Rizzieri D, Vermont C, Clough R, Kim C, Dodge R, Prosnitz L. Radiation dose selection in Hodgkin’s disease patients with large mediastinal adenopathy treated with combined modality therapy. International Journal Of Radiation Oncology • Biology • Physics 2000, 48: 1097-1105. PMID: 11072168, DOI: 10.1016/s0360-3016(00)00695-7.
- Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous‐cell carcinoma of the cervixRoberts K, Urdaneta N, Vera R, Vera A, Gutierrez E, Aguilar Y, Ott S, Medina I, Sempere P, Rockwell S, Sartorelli A, Fischer D, Fischer J. Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous‐cell carcinoma of the cervix. International Journal Of Cancer 2000, 90: 206-223. PMID: 10993961, DOI: 10.1002/1097-0215(20000820)90:4<206::aid-ijc4>3.0.co;2-o.
- Dosimetric effects of edema in permanent prostate seed implants: a rigorous solutionChen Z, Yue N, Wang X, Roberts K, Peschel R, Nath R. Dosimetric effects of edema in permanent prostate seed implants: a rigorous solution. International Journal Of Radiation Oncology • Biology • Physics 2000, 47: 1405-1419. PMID: 10889396, DOI: 10.1016/s0360-3016(00)00549-6.
- Dosimetric penumbra effects in catheter-based intravascular brachytherapy using a centered photon or beta line source.Yue N, Nath R, Roberts K. Dosimetric penumbra effects in catheter-based intravascular brachytherapy using a centered photon or beta line source. Cardiovascular Revascularization Medicine 2000, 2: 32-8. PMID: 11229060.
- Long‐term complications with prostate implants: Iodine‐125 vs. palladium‐103Peschel R, Chen Z, Roberts K, Nath R. Long‐term complications with prostate implants: Iodine‐125 vs. palladium‐103. International Journal Of Cancer 1999, 7: 278-288. PMID: 10580897, DOI: 10.1002/(sici)1520-6823(1999)7:5<278::aid-roi3>3.0.co;2-3.
- Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemiaJillella A, Doria R, Khan K, Zelterman D, Ahmad Y, Smith B, Holmes W, Becker P, Roberts K, Rappeport J. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia. Bone Marrow Transplantation 1999, 23: 1095-1100. PMID: 10382947, DOI: 10.1038/sj.bmt.1701786.
- 121 Early results of a randomized trial of mitomycin c as an adjunct to radical radiotherapy in the treatment of locally advanced squamous cell carcinoma of the cervixRoberts K, Urdaneta N, Vera R, Vera A, Gutierrez E, Aguilar Y, Ott S, Rockwell S, Fischer D, Fischer J. 121 Early results of a randomized trial of mitomycin c as an adjunct to radical radiotherapy in the treatment of locally advanced squamous cell carcinoma of the cervix. International Journal Of Radiation Oncology • Biology • Physics 1999, 45: 210. DOI: 10.1016/s0360-3016(99)90139-6.
- 135 Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapyElconin J, Roberts K, Vermont C, Rizzeri D, Clough R, Prosnitz L. 135 Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy. International Journal Of Radiation Oncology • Biology • Physics 1999, 45: 216. DOI: 10.1016/s0360-3016(99)90153-0.
- Gamma Knife Stereotactic Radiosurgical Treatment for Refractory Trigeminal Neuralgiade Lotbinière A, Lee S, Nijensohn D, Knisely J, Roberts K. Gamma Knife Stereotactic Radiosurgical Treatment for Refractory Trigeminal Neuralgia. Stereotactic And Functional Neurosurgery 1999, 73: 71-71. PMID: 10853104, DOI: 10.1159/000029757.
- Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine‐125 interstitial implantsNath R, Roberts K, Ng M, Peschel R, Chen Z. Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine‐125 interstitial implants. Medical Physics 1998, 25: 2293-2307. PMID: 9874821, DOI: 10.1118/1.598440.
- Effective Treatment of Stage I Uterine Papillary Serous Carcinoma with High Dose-Rate Vaginal Apex Radiation (192Ir) and ChemotherapyTurner B, Knisely J, Kacinski B, Haffty B, Gumbs A, Roberts K, Frank A, Peschel R, Rutherford T, Edraki B, Kohorn E, Chambers S, Schwartz P, Wilson L. Effective Treatment of Stage I Uterine Papillary Serous Carcinoma with High Dose-Rate Vaginal Apex Radiation (192Ir) and Chemotherapy. International Journal Of Radiation Oncology • Biology • Physics 1998, 40: 77-84. PMID: 9422561, DOI: 10.1016/s0360-3016(97)00581-6.
- Treatment of recurrent pelvic and selected primary gynecologic malignancies with 241AmChung J, Roberts K, Peschel R, Nath R, Pourang R, Kacinski B, Wilson L. Treatment of recurrent pelvic and selected primary gynecologic malignancies with 241Am. International Journal Of Cancer 1997, 5: 227-234. PMID: 9372545, DOI: 10.1002/(sici)1520-6823(1997)5:5<227::aid-roi3>3.0.co;2-#.
- Vascular irradiation for the prevention of restenosis after angioplasty: A new application for radiotherapyNath R, Roberts K. Vascular irradiation for the prevention of restenosis after angioplasty: A new application for radiotherapy. International Journal Of Radiation Oncology • Biology • Physics 1996, 36: 977-979. PMID: 8960533, DOI: 10.1016/s0360-3016(96)00441-5.
- Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation.Salloum E, Doria R, Schubert W, Zelterman D, Holford T, Roberts K, Farber L, Kiehl R, Cardinale J, Cooper D. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. Journal Of Clinical Oncology 1996, 14: 2435-43. PMID: 8823321, DOI: 10.1200/jco.1996.14.9.2435.
- Radiation Therapy as Exclusive Treatment for Medically Inoperable Patients with Stage I and II Endometrioid Carcinoma of the EndometriumFishman D, Roberts K, Chambers J, Kohorn E, Schwartz P, Chambers S. Radiation Therapy as Exclusive Treatment for Medically Inoperable Patients with Stage I and II Endometrioid Carcinoma of the Endometrium. Gynecologic Oncology 1996, 61: 189-196. PMID: 8626131, DOI: 10.1006/gyno.1996.0123.
- 2101 Post-operative high dose rate vaginal apex brachytherapy in stage I endometrial adenocarcinomaGumbs A, Turner B, Knisely J, Kacinski B, Roberts K, Peschel R, Haffty B, Rutherford T, Edraki B, Schwartz P, Wilson L. 2101 Post-operative high dose rate vaginal apex brachytherapy in stage I endometrial adenocarcinoma. International Journal Of Radiation Oncology • Biology • Physics 1996, 36: 327. DOI: 10.1016/s0360-3016(97)85677-5.
- 121 Preliminary results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous cell carcinoma of the cervixRoberts K, Urdaneta N, Vera R, Vera A, Gutierrez E, Rockwell S, Sartorelli A, Fischer D, Fischer J. 121 Preliminary results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous cell carcinoma of the cervix. International Journal Of Radiation Oncology • Biology • Physics 1996, 36: 219. DOI: 10.1016/s0360-3016(97)85462-4.
- Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.Salloum E, Doria R, Farber L, Roberts K, Cooper D. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study. The Cancer Journal 1995, 1: 267-73. PMID: 9166487.
- 1007 Treatment of selected primary gynecologic and pelvic malignancies with 241AmericiumChung J, Peschel R, Kacinski B, Nath R, Pourang R, Roberts K, Fischer D, Chambers J, Schwartz P, Wilson L. 1007 Treatment of selected primary gynecologic and pelvic malignancies with 241Americium. International Journal Of Radiation Oncology • Biology • Physics 1995, 32: 226. DOI: 10.1016/0360-3016(95)97833-m.
- Combined chemotherapy and radiotherapy for Hodgkin's disease.Prosnitz L, Roberts K. Combined chemotherapy and radiotherapy for Hodgkin's disease. Oncology 1992, 6: 113-28; discussion 131-2, 137. PMID: 1533138.